Patents by Inventor Cristian R. FRANCO

Cristian R. FRANCO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled release dosage form
    Patent number: 10213402
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: February 26, 2019
    Assignee: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. Meyer, Cristian R. Franco, Gustavo A. Fischbein, Alejandro A. Aguilar, Claude E. Wright
  • Controlled release dosage form
    Patent number: 10213404
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: February 26, 2019
    Assignee: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. Meyer, Cristian R. Franco, Gustavo A. Fischbein, Alejandro A. Aguilar, Claude E. Wright
  • Controlled release dosage form
    Patent number: 10213403
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: February 26, 2019
    Assignee: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. Meyer, Cristian R. Franco, Gustavo A. Fischbein, Alejandro A. Aguilar, Claude E. Wright
  • Controlled release dosage form with enhanced pharmacokinetics
    Patent number: 10172800
    Abstract: The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: January 8, 2019
    Assignee: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. Meyer, Cristian R. Franco, Gustavo A. Fischbein, Claude E. Wright
  • DOSE-DUMPING RESISTANT CONTROLLED RELEASE DOSAGE FORM
    Publication number: 20180221360
    Abstract: The present invention provides a simple and improved dosage form that provides a controlled release of methylphenidate contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to methylphenidate. The dosage form exhibits improved resistance to alcohol-related dose dumping.
    Type: Application
    Filed: July 21, 2017
    Publication date: August 9, 2018
    Applicant: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: HERNAN D. BENEDETTI, CRISTIAN R. FRANCO, GUIDO S. BIGATTI, JOAQUINA FAOUR, ANA C. PASTINI
  • Controlled Release Dosage Form
    Publication number: 20180200214
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Application
    Filed: March 13, 2018
    Publication date: July 19, 2018
    Applicant: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. MEYER, Cristian R. FRANCO, Gustavo A. FISCHBEIN, Alejandro A. AGUILAR, Claude E. WRIGHT
  • Controlled Release Dosage Form
    Publication number: 20180200215
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Application
    Filed: March 13, 2018
    Publication date: July 19, 2018
    Applicant: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. MEYER, Cristian R. FRANCO, Gustavo A. FISCHBEIN, Alejandro A. AGUILAR, Claude E. WRIGHT
  • Dose-dumping resistant controlled release dosage form
    Patent number: 9855258
    Abstract: The present invention provides a simple and improved dosage form that is capable of providing a controlled release of methylphenidate contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to methylphenidate. The dosage form exhibits improved resistance to alcohol-related dose dumping.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: January 2, 2018
    Assignee: Osmotica Kereskedelmi és Szolgáltató KFT
    Inventors: Hernan D. Benedetti, Cristian R. Franco, Guido S. Bigatti, Joaquina Faour, Ana C. Pastini
  • Controlled Release Dosage Form
    Publication number: 20170354625
    Abstract: The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Application
    Filed: August 18, 2017
    Publication date: December 14, 2017
    Applicant: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. MEYER, Cristian R. FRANCO, Gustavo A. FISCHBEIN, Alejandro A. AGUILAR, Claude E. WRIGHT
  • Controlled Release Dosage Form
    Publication number: 20170340592
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Application
    Filed: August 10, 2017
    Publication date: November 30, 2017
    Applicant: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. MEYER, Cristian R. FRANCO, Gustavo A. FISCHBEIN, Alejandro A. AGUILAR, Claude E. WRIGHT
  • Controlled Release Dosage Form with Enhanced Pharmacokinetics
    Publication number: 20170340570
    Abstract: The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Application
    Filed: August 10, 2017
    Publication date: November 30, 2017
    Applicant: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. MEYER, Cristian R. FRANCO, Gustavo A. FISCHBEIN, Claude E. WRIGHT
  • Dose-dumping resistant controlled release dosage form
    Patent number: 9827234
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of methylphenidate contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to methylphenidate. The dosage form exhibits improved resistance to alcohol-related dose dumping.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: November 28, 2017
    Assignee: Osmotica Kereskedelmi és Szolgáltató KFT
    Inventors: Hernan D. Benedetti, Cristian R. Franco, Guido S. Bigatti, Joaquina Faour, Ana C. Pastini
  • Controlled release dosage form
    Patent number: 9801841
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: October 31, 2017
    Assignee: Osmotica Kereskedelmi és Szolgáltató KFT
    Inventors: Glenn A. Meyer, Cristian R. Franco, Gustavo A. Fischbein, Alejandro A. Aguilar, Claude E. Wright
  • Controlled Release Dosage Form
    Publication number: 20170216236
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Application
    Filed: April 20, 2017
    Publication date: August 3, 2017
    Applicant: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. MEYER, Cristian R. FRANCO, Gustavo A. FISCHBEIN, Alejandro A. AGUILAR, Claude E. WRIGHT
  • Dose-dumping resistant controlled release dosage form
    Patent number: 9707217
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of methylphenidate contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to methylphenidate. The dosage form exhibits improved resistance to alcohol-related dose dumping.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: July 18, 2017
    Assignee: Osmotica Kereskedelmi es Szolgaltato KFT
    Inventors: Hernan D. Benedetti, Cristian R. Franco, Guido S. Bigatti, Joaquina Faour, Ana C. Pastini
  • Controlled release dosage form
    Patent number: 9655858
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: May 23, 2017
    Assignee: Osmotica Kereskedelmi es Szolgaltato KFT
    Inventors: Glenn A. Meyer, Cristian R. Franco, Gustavo A. Fischbein, Alejandro A. Aguilar, Claude E. Wright
  • Controlled release dosage form
    Patent number: 9585843
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: March 7, 2017
    Assignee: Osmotica Kereskedelmi es Szoloaltato Kft
    Inventors: Glenn A. Meyer, Cristian R. Franco, Gustavo A. Fischbein, Alejandro A. Aguilar, Claude E. Wright
  • Controlled release dosage form
    Patent number: 9579289
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: February 28, 2017
    Assignee: Osmotica Kereskedelmi es Szolgaltato Kft
    Inventors: Glenn A. Meyer, Cristian R. Franco, Gustavo A. Fischbein, Alejandro A. Aguilar, Claude E. Wright
  • Controlled Release Dosage Form
    Publication number: 20160263043
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Application
    Filed: February 19, 2016
    Publication date: September 15, 2016
    Applicant: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. MEYER, Cristian R. FRANCO, Gustavo A. FISCHBEIN, Alejandro A. AGUILAR, Claude E. WRIGHT
  • Controlled Release Dosage Form
    Publication number: 20160243072
    Abstract: The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
    Type: Application
    Filed: May 4, 2016
    Publication date: August 25, 2016
    Applicant: OSMOTICA KERESKEDELMI ES SZOLGALTATO KFT
    Inventors: Glenn A. MEYER, Cristian R. FRANCO, Gustavo A. FISCHBEIN, Alejandro A. AGUILAR, Claude E. WRIGHT